Amanat Acquisition, a blank check company targeting biotech and life sciences, filed on Friday with the SEC to raise up to $75 million in an initial public offering. Amanat Acquisition is led Chairman Sandeep Kulkarni, an experienced biotech executive who currently serves as CEO of Zura Bio, and CEO and Director Pavan Cheruvu, who previously served as CEO of Bitterroot Bio and Sio Gene Therapies. The SPAC plans to target the healthcare industry, particularly the biotechnology and life science sectors.
Read the full article: Healthcare SPAC Amanat Acquisition Files for a $75M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/118410/Healthcare-SPAC-Amanat-Acquisition-files-for-a-$75-million-IPO